Binimetinib versus dacarbazine in patients with advanced NRAS -mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial
Dummer, Reinhard, Prof, Schadendorf, Dirk, Prof, Ascierto, Paolo A, MD, Arance, Ana, MD, Dutriaux, Caroline, MD, Di Giacomo, Anna Maria, MD, Rutkowski, Piotr, Prof, Del Vecchio, Michele, MD, Gutzmer, Ralf, Prof, Mandala, Mario, MD, Thomas, Luc, Prof, Demidov, Lev, Prof, Garbe, Claus, Prof, Hogg, David, MD, Liszkay, Gabriella, Prof, Queirolo, Paola, MD, Wasserman, Ernesto, MD, Ford, James, MS, Weill, Marine, MSc, Sirulnik, L Andres, MD, Jehl, Valentine, MSc, Bozón, Viviana, MD, Long, Georgina V, Prof, Flaherty, Keith, MD
Published in The lancet oncology (01.04.2017)
Published in The lancet oncology (01.04.2017)
Get full text
Journal Article
Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial
Grob, Jean Jacques, Prof, Amonkar, Mayur M, PhD, Karaszewska, Boguslawa, MD, Schachter, Jacob, Prof, Dummer, Reinhard, Prof, Mackiewicz, Andrzej, Prof, Stroyakovskiy, Daniil, MD, Drucis, Kamil, MD, Grange, Florent, MD, Chiarion-Sileni, Vanna, MD, Rutkowski, Piotr, Prof, Lichinitser, Mikhail, Prof, Levchenko, Evgeny, MD, Wolter, Pascal, MD, Hauschild, Axel, Prof, Long, Georgina V, MD, Nathan, Paul, MD, Ribas, Antoni, Prof, Flaherty, Keith, MD, Sun, Peng, PhD, Legos, Jeffrey J, PhD, McDowell, Diane Opatt, MD, Mookerjee, Bijoyesh, MD, Schadendorf, Dirk, Prof, Robert, Caroline, MD
Published in The lancet oncology (01.10.2015)
Published in The lancet oncology (01.10.2015)
Get full text
Journal Article
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
Falchook, Gerald S, Dr, Lewis, Karl D, MD, Infante, Jeffrey R, MD, Gordon, Michael S, MD, Vogelzang, Nicholas J, MD, DeMarini, Douglas J, PhD, Sun, Peng, PhD, Moy, Christopher, MS, Szabo, Stephen A, BA, Roadcap, Lori T, MS, Peddareddigari, Vijay GR, MD, Lebowitz, Peter F, MD, Le, Ngocdiep T, MD, Burris, Howard A, MD, Messersmith, Wells A, MD, O'Dwyer, Peter J, Prof, Kim, Kevin B, MD, Flaherty, Keith, MD, Bendell, Johanna C, MD, Gonzalez, Rene, Prof, Kurzrock, Razelle, Prof, Fecher, Leslie A, MD
Published in The lancet oncology (01.08.2012)
Published in The lancet oncology (01.08.2012)
Get full text
Journal Article
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
Haas, Naomi B, Dr, Manola, Judith, MS, Uzzo, Robert G, Prof, Flaherty, Keith T, MD, Wood, Christopher G, Prof, Kane, Christopher, Prof, Jewett, Michael, Prof, Dutcher, Janice P, Prof, Atkins, Michael B, Prof, Pins, Michael, Prof, Wilding, George, Prof, Cella, David, Prof, Wagner, Lynne, Prof, Matin, Surena, Prof, Kuzel, Timothy M, Prof, Sexton, Wade J, Prof, Wong, Yu-Ning, MD, Choueiri, Toni K, MD, Pili, Roberto, Prof, Puzanov, Igor, MD, Kohli, Manish, MD, Stadler, Walter, Prof, Carducci, Michael, Prof, Coomes, Robert, DiPaola, Robert S, Prof
Published in The Lancet (British edition) (14.05.2016)
Published in The Lancet (British edition) (14.05.2016)
Get full text
Journal Article
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care
Bose, Debashish, MD, Meric-Bernstam, Funda, MD, Hofstetter, Wayne, MD, Reardon, David A, MD, Flaherty, Keith T, MD, Ellis, Lee M, Prof
Published in The lancet oncology (01.04.2010)
Published in The lancet oncology (01.04.2010)
Get full text
Journal Article
Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials
Flaherty, Keith T, MD, Hennig, Michael, PhD, Lee, Sandra J, PhD, Ascierto, Paolo A, MD, Dummer, Reinhard, Prof, Eggermont, Alexander M M, Prof, Hauschild, Axel, MD, Kefford, Richard, Prof, Kirkwood, John M, Prof, Long, Georgina V, PhD, Lorigan, Paul, MD, Mackensen, Andreas, Prof, McArthur, Grant, PhD, O'Day, Steven, MD, Patel, Poulam M, MD, Robert, Caroline, PhD, Schadendorf, Dirk, Prof
Published in The lancet oncology (01.03.2014)
Published in The lancet oncology (01.03.2014)
Get full text
Journal Article
Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome
Lawrence, Nicholas F., BS, Hammond, Marc R., BS, Frederick, Dennie T., MS, Su, Yuhua, MS, Dias-Santagata, Dora, PhD, Deng, April, MD, PhD, Selim, M. Angelica, MD, Mahalingam, Meera, MD, PhD, FRCPath, Flaherty, Keith T., MD, Hoang, Mai P., MD
Published in Journal of the American Academy of Dermatology (01.09.2016)
Published in Journal of the American Academy of Dermatology (01.09.2016)
Get full text
Journal Article
Benefit, recurrence pattern, and toxicity to adjuvant anti-PD-1 monotherapy varies by ethnicity and melanoma subtype: An international multicenter cohort studyCapsule Summary
Xue Bai, MD, Aleigha R. Lawless, BS, Juliane A. Czapla, MS, Stefanie C. Gerstberger, MD, PhD, Benjamin C. Park, MD, Seungyeon Jung, BA, Rebecca Johnson, MN, Naoya Yamazaki, MD, PhD, Dai Ogata, MD, PhD, Yoshiyasu Umeda, MD, Caili Li, MB, Jun Guo, MD, PhD, Keith T. Flaherty, MD, Yasuhiro Nakamura, MD, PhD, Kenjiro Namikawa, MD, PhD, Georgina V. Long, MBBS, PhD, Alexander M. Menzies, MBBS, PhD, Douglas B. Johnson, MD, Ryan J. Sullivan, MD, Genevieve M. Boland, MD, PhD, Lu Si, MD
Published in JAAD international (01.06.2024)
Get full text
Published in JAAD international (01.06.2024)
Journal Article
Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patients
Mochel, Mark C., MD, Hammond, Marc R, Frederick, Dennie T, Alora-Palli, Maria B., MD, Piris, Adriano, MD, Flaherty, Keith T., MD, Hoang, Mai P., MD
Published in Journal of the American Academy of Dermatology (01.09.2015)
Published in Journal of the American Academy of Dermatology (01.09.2015)
Get full text
Journal Article
Commentary: Molecular testing in melanoma
Miller, David M., MD, PhD, Flaherty, Keith T., MD, Tsao, Hensin, MD, PhD
Published in Journal of the American Academy of Dermatology (01.05.2014)
Published in Journal of the American Academy of Dermatology (01.05.2014)
Get full text
Journal Article
Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
McArthur, Grant A, Prof, Chapman, Paul B, Prof, Robert, Caroline, MD, Larkin, James, MD, Haanen, John B, MD, Dummer, Reinhard, Prof, Ribas, Antoni, Prof, Hogg, David, Prof, Hamid, Omid, MD, Ascierto, Paolo A, MD, Garbe, Claus, Prof, Testori, Alessandro, MD, Maio, Michele, MD, Lorigan, Paul, MD, Lebbé, Celeste, Prof, Jouary, Thomas, MD, Schadendorf, Dirk, Prof, O'Day, Stephen J, MD, Kirkwood, John M., Prof, Eggermont, Alexander M, Prof, Dréno, Brigitte, Prof, Sosman, Jeffrey A, Prof, Flaherty, Keith T, MD, Yin, Ming, PhD, Caro, Ivor, MD, Cheng, Suzanne, PhD, Trunzer, Kerstin, PhD, Hauschild, Axel, Prof
Published in The lancet oncology (01.03.2014)
Published in The lancet oncology (01.03.2014)
Get full text
Journal Article
Drug targeting of oncogenic pathways in melanoma
Fecher, Leslie A, Amaravadi, Ravi K, Schuchter, Lynn M, Flaherty, Keith T
Published in Hematology/oncology clinics of North America (01.06.2009)
Published in Hematology/oncology clinics of North America (01.06.2009)
Get more information
Journal Article